PGxCare

Palo Alto, United States

PGxCare offers an AI capabilities, enabling analysis of pharmacogenetic data ensuring accurate results tailored to individual needs.

$1.5M raised

Mar 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PGxCare raised?

PGxCare has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in March 2024.

Who are PGxCare's investors?

PGxCare's investors include Roman Smolevskiy, ATEM Capital Fund LP.

Where is PGxCare headquartered?

PGxCare is headquartered in Palo Alto, United States.

What does PGxCare do?

PGxCare offers an AI capabilities, enabling analysis of pharmacogenetic data ensuring accurate results tailored to individual needs.

What stage is PGxCare at?

PGxCare is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 19, 2024.

MLA

"PGxCare — Funding & Investors." VCBacked, March 19, 2024, https://www.vcbacked.co/company/pgxcare. Accessed July 2, 2026.

APA

VCBacked. (2024). PGxCare — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/pgxcare

Wikipedia (cite web)

{{cite web |title=PGxCare — Funding & Investors |url=https://www.vcbacked.co/company/pgxcare |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 19, 2024.